MARKET

SEELQ

SEELQ

Seelos Therapeutics Inc
OTCPK
0.320
-0.010
-3.03%
Closed 15:24 12/11 EST
OPEN
0.330
PREV CLOSE
0.330
HIGH
0.350
LOW
0.320
VOLUME
1.13K
TURNOVER
382
52 WEEK HIGH
848.64
52 WEEK LOW
0.201
MARKET CAP
139.51K
P/E (TTM)
0.0020
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SEELQ last week (1202-1206)?
Weekly Report · 2d ago
Weekly Report: what happened at SEELQ last week (1125-1129)?
Weekly Report · 12/02 12:31
Weekly Report: what happened at SEELQ last week (1118-1122)?
Weekly Report · 11/25 12:18
Weekly Report: what happened at SEEL last week (1111-1115)?
Weekly Report · 11/18 12:14
SEELOS THERAPEUTICS COMMENCES CHAPTER 11 PROCEEDINGS- COURT FILING
Reuters · 11/16 17:46
RFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares up
Seeking Alpha · 11/15 11:02
Weekly Report: what happened at SEEL last week (1104-1108)?
Weekly Report · 11/11 12:35
Weekly Report: what happened at SEEL last week (1028-1101)?
Weekly Report · 11/04 12:30
More
About SEELQ
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The Company operates under one segment which develops pharmaceutical products. The Company's programs include SLS-002 for the potential treatment of acute suicidal ideation and behavior (ASIB) in patients with major depressive disorder (MDD) and SLS-005 for the potential treatment of amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia (SCA). SLS-002 is intranasal racemic ketamine with two investigational new drug applications (INDs). SLS-005 is used for the potential treatment of Sanfilippo Syndrome. SLS-005 is IV trehalose, a protein stabilizer that crosses the blood-brain barrier and activates autophagy and the lysosomal pathway. The Company's ongoing preclinical programs include SLS-004, SLS-006, and SLS-007.

Webull offers Seelos Therapeutics Inc stock information, including OTCPK: SEELQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEELQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SEELQ stock methods without spending real money on the virtual paper trading platform.